Racecadotril treatment of infantile acute watery diarrhea in 230 patients with observation.doc

 PAGE \* MERGEFORMAT 6 Racecadotril treatment of infantile acute watery diarrhea in 230 patients with observation [Keywords:] racecadotril infants with acute watery diarrhea Is a group of infants with diarrhea by multiple pathogens, multiple factors caused an increase in stool frequency and stool characteristics of the pediatric common change is the most common of the digestive tract of infant syndrome, especially acute watery diarrhea in common and causing malnutrition in children, growth stunting and death of one of the main [1]. Treatment is symptomatic treatment, there are a number of reported domestic racecadotril treatment with positive results [2,3]. our hospital with racecadotril treatment of infantile acute watery diarrhea in 230 patients, but also achieve a satisfactory effect, are reported below. Materials and Methods 1. Clinical Data Select July 2007 ~ December 2008 in our hospital 438 cases of acute watery diarrhea were the object of study, the patients were subject to the following criteria: age 1 month to 3 years old, watery stool, pus, mucus-free blood disease within 72 hours, stool: Most normal stool routine check, a handful of small fat globules, or occasionally white, not used after the onset of antibiotics, or astringent antidiarrheal can be treated with oral medication, in addition to diarrhea, not outside the combined other diseases. were randomly divided into control group (208 patients) and treatment group (230 cases, the two groups in gender, age, clinical symptoms, course and severity of disease and so there was no significant difference (Pgt; 0.05 . 2. Treatment Both groups were given conventional fluid replacement, correction acid, added electrolytes, antibiotics, mucosal protective agents such as montmorillonite powder treatment. The treatment group was based on the use racecadotril particles (Po Ming Dula goods, Sichuan Gabriel Pharmaceutical Limited Company, registration number: Zhunzi each 1.5 mg